{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:37:42Z","timestamp":1794667062676,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2021C03077"],"award-info":[{"award-number":["2021C03077"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404122"],"award-info":[{"award-number":["82404122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04349-8","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:25:58Z","timestamp":1747239958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human umbilical cord mesenchymal stem cell therapy for atopic dermatitis through inhibition of neutrophil chemotaxis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jinjin","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-0893","authenticated-orcid":false,"given":"Lijiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"4349_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","volume":"21","author":"T Bieber","year":"2022","unstructured":"Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21:21\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"4349_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S. Atopic dermatitis. N Engl J Med. 2021;384:1136\u201343.","journal-title":"N Engl J Med"},{"key":"4349_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","volume":"405","author":"E Guttman-Yassky","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405:583\u201396.","journal-title":"Lancet"},{"key":"4349_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345\u201360.","journal-title":"Lancet"},{"key":"4349_CR5","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3390\/ijms22084130","volume":"22","author":"J Sroka-Tomaszewska","year":"2021","unstructured":"Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021;22:4130.","journal-title":"Int J Mol Sci"},{"key":"4349_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-023-00992-4","volume":"20","author":"P Facheris","year":"2023","unstructured":"Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. Cell Mol Immunol. 2023;20:448\u201374.","journal-title":"Cell Mol Immunol"},{"key":"4349_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol. 2021;61:324\u201338.","journal-title":"Clin Rev Allergy Immunol"},{"key":"4349_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40265-022-01722-2","volume":"82","author":"E Freitas","year":"2022","unstructured":"Freitas E, Gooderham M, Torres T. New topical therapies in development for atopic dermatitis. Drugs. 2022;82:843\u201353.","journal-title":"Drugs"},{"key":"4349_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-020-01335-7","volume":"80","author":"M Newsom","year":"2020","unstructured":"Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and emerging systemic treatments for atopic dermatitis. Drugs. 2020;80:1041\u201352.","journal-title":"Drugs"},{"key":"4349_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","volume":"148","author":"R Chovatiya","year":"2021","unstructured":"Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021;148:927\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"4349_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41573-023-00735-0","volume":"22","author":"T Bieber","year":"2023","unstructured":"Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov. 2023;22:662\u201380.","journal-title":"Nat Rev Drug Discov"},{"key":"4349_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53: e12712.","journal-title":"Cell Prolif"},{"key":"4349_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.stem.2022.10.001","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Fang J, Liu B, Shao C, Shi Y. Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022;29:1515\u201330.","journal-title":"Cell Stem Cell"},{"key":"4349_CR14","doi-asserted-by":"publisher","first-page":"1092668","DOI":"10.3389\/fimmu.2023.1092668","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Xiao M, Ma K, Li H, Ran M, Yang S, et al. Therapeutic effects of mesenchymal stem cells and their derivatives in common skin inflammatory diseases: atopic dermatitis and psoriasis. Front Immunol. 2023;14:1092668.","journal-title":"Front Immunol"},{"key":"4349_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485\u201398.","journal-title":"Nat Rev Immunol"},{"key":"4349_CR16","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2147\/IJN.S494574","volume":"20","author":"ME Al-Masawa","year":"2025","unstructured":"Al-Masawa ME, Elfawy LA, Ng CY, Ng MH, Law JX. Mesenchymal stromal cell-derived extracellular vesicles in the management of atopic dermatitis: a scoping review of therapeutic opportunities and challenges. Int J Nanomedicine. 2025;20:2673\u201393.","journal-title":"Int J Nanomedicine"},{"key":"4349_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13287-020-02011-z","volume":"11","author":"Q Xie","year":"2020","unstructured":"Xie Q, Liu R, Jiang J, Peng J, Yang C, Zhang W, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res Ther. 2020;11:519.","journal-title":"Stem Cell Res Ther"},{"key":"4349_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13287-023-03365-w","volume":"14","author":"C Hua","year":"2023","unstructured":"Hua C, Liang Q, Chen S, Zhu J, Tang Y, Chen X, et al. Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model. Stem Cell Res Ther. 2023;14:147.","journal-title":"Stem Cell Res Ther"},{"key":"4349_CR19","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1038\/s41598-019-42964-7","volume":"9","author":"JY Song","year":"2019","unstructured":"Song JY, Kang HJ, Ju HM, Park A, Park H, Hong JS, et al. Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses. Sci Rep. 2019;9:6623.","journal-title":"Sci Rep"},{"key":"4349_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jcb.30365","volume":"124","author":"J Najera","year":"2023","unstructured":"Najera J, Hao J. Recent advance in mesenchymal stem cells therapy for atopic dermatitis. J Cell Biochem. 2023;124:181\u20137.","journal-title":"J Cell Biochem"},{"key":"4349_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.2401","volume":"35","author":"HS Kim","year":"2017","unstructured":"Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS, Kim TY. Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: Phase I\/IIa studies. Stem Cells. 2017;35:248\u201355.","journal-title":"Stem Cells"},{"key":"4349_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10020-021-00272-9","volume":"27","author":"F Liu","year":"2021","unstructured":"Liu F, Song DY, Huang J, Yang HQ, You D, Ni JD. Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2. Mol Med. 2021;27:12.","journal-title":"Mol Med"},{"key":"4349_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/bjc.2017.55","volume":"116","author":"L Xu","year":"2017","unstructured":"Xu L, Zhu Y, Shao J, Chen M, Yan H, Li G, et al. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1. Br J Cancer. 2017;116:1027\u201336.","journal-title":"Br J Cancer"},{"key":"4349_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13287-024-03800-6","volume":"15","author":"A Jafarzadeh","year":"2024","unstructured":"Jafarzadeh A, Pour Mohammad A, Keramati H, Zeinali R, Khosravi M, Goodarzi A. Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials. Stem Cell Res Ther. 2024;15:176.","journal-title":"Stem Cell Res Ther"},{"key":"4349_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16660","volume":"24","author":"A Jafarzadeh","year":"2025","unstructured":"Jafarzadeh A, Mohammad AP, Goodarzi A. A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo. J Cosmet Dermatol. 2025;24: e16660.","journal-title":"J Cosmet Dermatol"},{"key":"4349_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12: 749192.","journal-title":"Front Immunol"},{"key":"4349_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.659621","volume":"12","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Zhang S, Guo WZ, Li XK. The unique immunomodulatory properties of MSC-derived exosomes in organ transplantation. Front Immunol. 2021;12: 659621.","journal-title":"Front Immunol"},{"key":"4349_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"4349_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.it.2019.05.001","volume":"40","author":"M Phillipson","year":"2019","unstructured":"Phillipson M, Kubes P. The healing power of neutrophils. Trends Immunol. 2019;40:635\u201347.","journal-title":"Trends Immunol"},{"key":"4349_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaci.2012.06.044","volume":"130","author":"DF Choy","year":"2012","unstructured":"Choy DF, Hsu DK, Seshasayee D, Fung MA, Modrusan Z, Martin F, et al. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol. 2012;130:1335-43.e5.","journal-title":"J Allergy Clin Immunol"},{"key":"4349_CR31","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.13382","author":"D Pavlenko","year":"2023","unstructured":"Pavlenko D, Todurga Seven Z, Bystrom L, Markan A, Verpile R, Ishida H, et al. Crisaborole inhibits itch and pain by preventing neutrophil infiltration in a mouse model of atopic dermatitis. Acta Derm Venereol. 2023. https:\/\/doi.org\/10.2340\/actadv.v103.13382.","journal-title":"Acta Derm Venereol"},{"key":"4349_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48448","volume":"8","author":"CM Walsh","year":"2019","unstructured":"Walsh CM, Hill RZ, Schwendinger-Schreck J, Deguine J, Brock EC, Kucirek N, et al. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife. 2019;8: e48448.","journal-title":"Elife"},{"key":"4349_CR33","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1111\/all.15505","volume":"77","author":"A \u00d6zcan","year":"2022","unstructured":"\u00d6zcan A, Boyman O. Mechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity. Allergy. 2022;77:3567\u201383.","journal-title":"Allergy"},{"key":"4349_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3390\/cells11101683","volume":"11","author":"P Das","year":"2022","unstructured":"Das P, Mounika P, Yellurkar ML, Prasanna VS, Sarkar S, Velayutham R, et al. Keratinocytes: an enigmatic factor in atopic dermatitis. Cells. 2022;11:1683.","journal-title":"Cells"},{"key":"4349_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cei.13575","volume":"204","author":"P Chieosilapatham","year":"2021","unstructured":"Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez JV, Peng G, Yue H, et al. Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol. 2021;204:296\u2013309.","journal-title":"Clin Exp Immunol"},{"key":"4349_CR36","doi-asserted-by":"publisher","first-page":"1856460","DOI":"10.1080\/19420862.2020.1856460","volume":"12","author":"MJ Alam","year":"2020","unstructured":"Alam MJ, Xie L, Ang C, Fahimi F, Willingham SB, Kueh AJ, et al. Therapeutic blockade of CXCR2 rapidly clears inflammation in arthritis and atopic dermatitis models: demonstration with surrogate and humanized antibodies. MAbs. 2020;12:1856460.","journal-title":"MAbs"},{"key":"4349_CR37","doi-asserted-by":"publisher","first-page":"1068260","DOI":"10.3389\/fimmu.2022.1068260","volume":"13","author":"IH Huang","year":"2022","unstructured":"Huang IH, Chung WH, Wu PC, Chen CB. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review. Front Immunol. 2022;13:1068260.","journal-title":"Front Immunol"},{"key":"4349_CR38","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.3390\/jcm11154431","volume":"11","author":"A Tsiogka","year":"2022","unstructured":"Tsiogka A, Kyriazopoulou M, Kontochristopoulos G, Nicolaidou E, Stratigos A, Rigopoulos D, et al. The JAK\/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: A systematic review. J Clin Med. 2022;11:4431.","journal-title":"J Clin Med"},{"key":"4349_CR39","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/biomedicines11051303","volume":"11","author":"G Tsuji","year":"2023","unstructured":"Tsuji G, Yamamura K, Kawamura K, Kido-Nakahara M, Ito T, Nakahara T. Novel therapeutic targets for the treatment of atopic dermatitis. Biomedicines. 2023;11:1303.","journal-title":"Biomedicines"},{"key":"4349_CR40","doi-asserted-by":"publisher","first-page":"1558310","DOI":"10.3389\/fcell.2025.1558310","volume":"13","author":"L Xia","year":"2025","unstructured":"Xia L, Shao J, Yang Q, Zhang C, Xie Z, Wang L, et al. Repeat-dose toxicity of human umbilical cord mesenchymal stem cells via subcutaneous injection in NOG mice. Front Cell Dev Biol. 2025;13:1558310.","journal-title":"Front Cell Dev Biol"},{"key":"4349_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/17425255.2023.2279243","volume":"19","author":"J Shao","year":"2023","unstructured":"Shao J, Xia L, Ye Z, Yang Q, Zhang C, Shi Y, et al. A repeat-dose toxicity study of human umbilical cord mesenchymal stem cells in NOG mice by intravenous injection. Expert Opin Drug Metab Toxicol. 2023;19:857\u201366.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4349_CR42","doi-asserted-by":"publisher","first-page":"1273723","DOI":"10.3389\/fcell.2023.1273723","volume":"11","author":"W Pan","year":"2023","unstructured":"Pan W, Gu L, Yang H, Xu C, Yang Z, Lu Q, et al. Repeat-dose toxicity study of human umbilical cord mesenchymal stem cells in cynomolgus monkeys by intravenous and subcutaneous injection. Front Cell Dev Biol. 2023;11:1273723.","journal-title":"Front Cell Dev Biol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04349-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:25:59Z","timestamp":1747239959000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04349-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Female 5\u20137-week-old BALB\/c mice were obtained from the Experimental Animal Center of Hangzhou Medical College and Zhejiang Vital River Laboratory Animal Technology (Zhejiang, China). The mice were housed in barrier facilities under specific pathogen-free conditions and maintained under a 12-h light\/dark cycle, with unrestricted access to food and water. The animal study protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of Hangzhou Medical College under the project titled, \u201cResearch on Novel Diagnostic and Therapeutic Techniques for Dermatological, Venereological, and Rheumatological Immune Diseases- Development of Umbilical Cord Mesenchymal Stem Cell-Based Therapy for Atopic Dermatitis\u201d\u00a0(Approval No: 2024\u2013033; Date of Approval: April 11, 2024). The animal study has been reported according to ARRIVE 2.0 guidelines. The hUC-MSCs used in this study were provided for research purposes by S-Evans Biosciences. The supplier confirmed that original umbilical cord tissue collection was conducted following the protocol, \u201cCollection, Preparation, and Preservation of Umbilical Cord and Placental Stem Cells,\u201d approved by the Ethics Committee for Human Research at the Second Affiliated Hospital of Zhejiang University School of Medicine (Approval No. 2021\u20131135; Date of Approval: December 24, 2021); in addition, they confirmed that informed consent was obtained from all donors prior to tissue collection.\u00a0As this study was conducted on pre-collected, anonymized cells, and did not involve direct human participation, no additional ethics approval was required for their use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}